(Q43687450)

English

Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.

scientific article published in May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002. (English)

1 reference

Europe PubMed Central

25 November 2017

anti-retroviral agent

0 references

Rodolphe Thiébaut

2

object named as

R Thiébaut

1 reference

Europe PubMed Central

25 November 2017

Geneviève Chêne

3

object named as

G Chêne

1 reference

Europe PubMed Central

25 November 2017

François Dabis

8

object named as

F Dabis

1 reference

Europe PubMed Central

25 November 2017

author name string

F Bonnet

1

1 reference

Europe PubMed Central

25 November 2017

D Neau

4

1 reference

Europe PubMed Central

25 November 2017

J-L Pellegrin

5

1 reference

Europe PubMed Central

25 November 2017

P Mercié

6

1 reference

Europe PubMed Central

25 November 2017

J Beylot

7

1 reference

Europe PubMed Central

25 November 2017

R Salamon

9

1 reference

Europe PubMed Central

25 November 2017

P Morlat

10

1 reference

Europe PubMed Central

25 November 2017

Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA)

11

1 reference

Europe PubMed Central

25 November 2017

publication date

1 May 2005

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

6

1 reference

Europe PubMed Central

25 November 2017

3

1 reference

Europe PubMed Central

25 November 2017

198-205

1 reference

Europe PubMed Central

25 November 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Reconstitution of naive T cells during antiretroviral treatment of HIV-infected adults is dependent on age.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Risk of new AIDS diseases in people on triple therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00290.X

21 January 2018

Identifiers

10.1111/J.1468-1293.2005.00290.X

1 reference

Europe PubMed Central

25 November 2017

release_f3zkil2uvrfjpex4gzthyo4ixu

1 reference

https://api.fatcat.wiki/v0/release/f3zkil2uvrfjpex4gzthyo4ixu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43687450&oldid=2102512877"